financetom
OMCL
financetom
/
Healthcare
/
OMCL
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Omnicell, Inc.OMCL
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.

The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.

It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems.

In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings.

Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001.

Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.

Latest News >
Amundi's Q2 net inflows beat estimates on Asian contributions
Amundi's Q2 net inflows beat estimates on Asian contributions
Jul 25, 2024
PARIS (Reuters) - Amundi, Europe's biggest fund manager, posted better-than-expected quarterly inflows on Friday, driven by its Asian joint ventures amid a sustained demand for risk-averse products. Amundi's total assets under management (AUM) rose by 15.5 billion euros ($16.8 billion) in the second quarter to 2.16 trillion euros at end of June, setting a new record and reflecting growth of...
Swiss stocks - Factors to watch on July 26
Swiss stocks - Factors to watch on July 26
Jul 25, 2024
July 26 - Here are some of the main factors that may affect Swiss stocks on Friday: HOLCIM Reports Q2 results slightly ahead of forecasts. COMPANY STATEMENTS AMS OSRAM ( AUKUF ) Second quarter earnings release due. FORBO HOLDING Confirms spring outlook for full year 2024. VONTOBEL Half-year earnings release due. SULZER Posts Order Intake Above 2 billion Swiss francs...
JPMorgan launches in-house chatbot as AI-based research analyst, FT reports
JPMorgan launches in-house chatbot as AI-based research analyst, FT reports
Jul 25, 2024
July 26 (Reuters) - JPMorgan Chase ( JPM ) has begun rolling out a generative artificial intelligence (AI) product, telling employees that its own version of OpenAI's ChatGPT can do the work of a research analyst, the Financial Times reported on Friday. The lender, the biggest in the United States, has given employees of its asset and wealth management division...
Mercedes-Benz narrows 2024 outlook for cars profit margin
Mercedes-Benz narrows 2024 outlook for cars profit margin
Jul 25, 2024
(Reuters) -Mercedes-Benz on Friday narrowed its annual forecast for the profit margin in its core car division as the German luxury automaker continues to struggle amid model changeover and a subdued market environment in Asia. The company now expects an adjusted return on sales in the range of 10-11% this year, down from 10-12% expected before. Mercedes' cars division was...
Copyright 2023-2025 - www.financetom.com All Rights Reserved